Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 755 participants.

Also called NCT03911986

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 755 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03911986
Other papers using this trial's data
  • Risk-based screening for the evaluation of atrial fibrillation in general practice (R-BEAT): a randomized cross-over trial QJM : monthly journal of the Association of Physicians, 2025-03-01 DOI, PubMed 39786890, PMC12051387 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Ireland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03911986. Randomized; no masking; primary purpose screening. Start 2018-03-21 (actual); primary completion 2023-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial
Acronym
R-BEAT
Condition
Atrial Fibrillation and Flutter
Intervention (Device)
R Test 4 External Loop Recorder
Lead sponsor
National University of Ireland, Galway, Ireland (class: other)
Collaborator
Health Research Board, Ireland (class: other)

Record details

Record id
cardio:ct-nct03911986
Content hash
067fa07d6aedadf99612aa087d9f0455380a9d8d1e49fe78bb74c06a5a353a85